Archive: December 14 2020
Find relevant news articles from other European projects, below:
Browse our carefully curated library of the latest news and developments in all areas of immunotherapy here:
EHA-SWG Scientific Meeting on Immunotherapy | Multiple Myeloma: More than CAR-T
This selection of educational videos from the recent EHA-SWG Scientific Meeting on Immunotherapy address the latest and more innovative immune-therapeutic options for multiple myeloma patients - including bispecific antibodies, antibody-drug-conjugates and new immunomodulator drugs.
Now Available: The EHA-EBMT 3rd CAR T-Cell Meeting Scientific Program
Register now for the the 3rd European CAR T-cell Meeting, which will include a special focus on CAR-T research across Europe, the USA, and Asia; clinical implications and regulatory aspects; and broadened perspectives through the incorporation of patient organizations, nurses, and data managers.
SIERRA: Iomab-B for pre-HSCT AML
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the prospective Phase III SIERRA trial (NCT02665065) of targeted radiotherapy with iomab-B, an anti-CD45 monoclonal antibody, in relapsed/refractory acute myeloid leukemia (AML).